: Overexpression or depletion of miR-26b in GC cell lines. Two days after lenti-miLacZ or lentimiR-26b virus infection in AGS and AZ-521 cell lines, blasticidin (8 μg/ml) was added to the medium and stable clones selected. Images of stable cell lines were photographed using phase contrast and GFP staining. RT-qPCR was employed to determine induction fold of miR-26b. (B) Two days after miRZip-control and miRZip-26b virus infection into AGS and AZ-521 cell lines, puromycin (4 μg/ml) was added to the medium and stable clones selected. Images of stable cell lines were obtained using phase contrast and GFP staining. RT-qPCR was employed to determine suppression fold of miR-26b. Mann-Whitney U test was applied for comparison between the two groups.
lines. Assay of migration activities. The number of cells invading the Matrigel to the lower chamber was determined under conditions of overexpression (A) or (B) depletion of miR-26b in cell lines. Data are presented as mean values ± SEM. Mann-Whitney U test was applied for comparison between the two groups. Figure S3 : KPNA2 is a direct target of miR-26b. (A) iTRAQ, TargetScan and miRBase were used for prediction of potential targets of miR-26b. In total, 11 genes were selected as potential targets. (B) The luciferase reporter activity assay was performed on 60 bp 3′UTRs from the potential targets using AGS or AZ521 cells stably overexpressing miR-26b. Only KPNA2 displayed > 60% inhibition. (C) Conversely, the luciferase reporter activity assay was performed after depletion of miR-26b in the two GC cell lines. Data are presented as mean values ± SEM. Mann-Whitney U test was applied for comparison between the two groups. gene were established and selected with puromycin (4 μg/ml) for two weeks. Migration and invasion assays of AGS cells were performed after (A) depletion and overexpression of KPNA2 with shRNA was confirmed using western blot in AGS and AZ-521 cells. (B) KPNA2 depletion (shLuc or shKPNA2-1/-2) or (C) overexpression (Control or pKPNA2). Results were quantified for KPNA2 depletion and overexpression. KPNA2-depleted or -overexpressing AGS stable lines were established. Images of lung foci in (D) KPNA2 knockdown (shLuc or shKPNA2 plasmid) or (E) overexpression (control or pcDNA3-KPNA2 (CDS) plasmid) mice. Stable KPNA2-expressing clones were injected into the mouse tail vein (1 × 10 6 cells). All mice were sacrificed after 15 weeks. Images of lung metastases were photographed, and the results quantified (n = 3). Data are presented as mean values ± SEM. The Mann-Whitney U test was used for comparisons between the two groups. *p < 0.01, **p < 0.05, ***p < 0.001.
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